Arbor Pharma Announces Acquisition Of Xenoport At A 60% Premium
Shares of XenoPort, Inc. XNPT 56.7%, a small-cap bio-pharmaceutical company that focuses on the commercializing HORIZANT in the United States for the treatment of adults with moderate to severe ...
